You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽倫生物(688163.SH):蛇藥片等中成藥以及民間中草藥土方也常用於蛇傷治療
格隆匯 07-04 15:08

格隆匯7月4日丨有投資者向賽倫生物(688163.SH)提問:公司抗蛇毒血清的市場競爭格局如何?抗蛇毒血清和中成藥之間是否存在競爭關係?

賽倫生物回覆:目前國內除了抗蛇毒血清這種西醫治療方法外,蛇藥片等中成藥以及民間中草藥土方也常用於蛇傷治療。

從藥品功效來看,抗蛇毒血清的藥理作用是“含有特異性抗體,具有中和相應蛇毒的作用”,而蛇傷中常用的中藥及中成藥的主要功效為清熱解毒、利尿消腫、止痛、止血等等。 二者的治療功效不同。

《2018年中國蛇傷救治專家共識》指出,“抗蛇毒血清是治療蛇咬傷中毒唯一切實有效的抗蛇毒藥”,中醫中藥“對輕中度中毒者可能有一定的療效” ,“被毒蛇咬傷後越早使用抗蛇毒血清,療效越好,恢復越快,預後越佳”。從臨牀治療角度,在具備可選擇抗蛇毒血清產品的前提下,抗蛇毒血清產品是毒蛇咬傷患者生命安全的保障,屬於蛇傷治療中不可替代的治療手段,中藥及中成藥可用於蛇傷的輔助治療。

但是,目前仍然存在僅採用中成藥、中草藥等中醫藥治療毒蛇咬傷的情況,主要是由於抗蛇毒血清的推廣力度不足以及相關急救知識的缺乏。近幾年來,公司正在通過大力宣傳蛇傷規範救治知識、開展賽倫100蛇傷防治項目等促進蛇傷臨牀科學治療規範的普及。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account